Oklahoma judge signs off on state's $85 million settlement with a generic drugmaker, closing one chapter of ongoing litigation against drugmakers charged for their role in the opioid crisis.
An Oklahoma judge signed off on the state's settlement with a generic drugmaker on Monday, closing one chapter of ongoing litigation against drugmakers charged for their role in the opioid crisis.
“The resources and terms of the agreement will help abate the ongoing crisis the state is facing, help prevent doctors and Oklahomans from being misled by marketing materials and provides law enforcement with another investigative tool to help us shut down pill mills and illicit enterprises.” Oklahoma Attorney General Mike Hunter said in a statement after the settlement.
The settlement stipulates that Teva admits no wrongdoing, saying that it should not be"construed to be a concession as to any claim...admission, evidence of any violation of any statute or law" or"evidence of any liability or wrongdoing by Teva."
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
House passes emergency funding bill for migrant care crisisWASHINGTON (AP) — It took last-minute changes and a full-court press by top Democratic leaders, but the House passed with relative ease Tuesday a $4.5 billion emergency border aid package to care...
Leer más »
Oklahoma judge approves Teva's $85 million opioid settlementAn Oklahoma judge on Monday approved a revised $85 million settlement with Teva ...
Leer más »
Oklahoma judge approves Teva's $85 million opioid settlementAn Oklahoma judge on Monday approved a revised $85 million (£66.7 million) settl...
Leer más »
Opioid maker settles lawsuit with Oklahoma for $85 millionAn Oklahoma judge signed off on the agreement with Teva Pharmaceuticals calling for the funds to be used to help abate the state's opioid crisis.
Leer más »
Generic-drug makers colluded to inflate prices, lawsuit saysRepresentatives of some of the nation's largest generic-drug manufacturers used code words to collude with competitors, according to a federal lawsuit.
Leer más »